Parul Barry is an Oncology physician affiliated with University of Pittsburgh. OpenAlex indexes 89 publications with 563 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Halket St
Pittsburgh, PA 152133108
Telephone
412-641-4600Provider last certified this registry record 1 Jul 2020.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20255 payments
- GT Medical Technologies, IncProgram year20251 payment
- Novocure Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Azole Antifungal100%Fluconazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline
Journal of Clinical Oncology
2025 - Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline
Practical Radiation Oncology
2025 - Postmastectomy Radiation Therapy: An ASTRO/ASCO/SSO Clinical Practice Guideline
Annals of Surgical Oncology
2025 - ACR Appropriateness Criteria® Staging and Follow-Up of Ovarian Cancer: 2025 Update
Journal of the American College of Radiology
2025 - The Society for Women in Radiation Oncology 5 Years Later: Connection, Representation, and Inclusivity Matter
Practical Radiation Oncology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”